pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects
出版年份 2021 全文链接
标题
pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects
作者
关键词
Nanomedicine, pH-responsive polymersomes, Doxorubicin, Antitumor activity, Cardiotoxicity
出版物
JOURNAL OF CONTROLLED RELEASE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-03-12
DOI
10.1016/j.jconrel.2021.03.013
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liposomal Drug Delivery Systems and Anticancer Drugs
- (2018) Temidayo Olusanya et al. MOLECULES
- Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
- (2018) Barry Neun et al. MOLECULES
- Drug-Induced Pseudoallergy: A Review of the Causes and Mechanisms
- (2017) Bo Zhang et al. PHARMACOLOGY
- Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies
- (2017) Ana Catarina Alves et al. Scientific Reports
- Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints
- (2017) Tracy Rupp et al. JAMA Internal Medicine
- Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron
- (2016) Iain C. Macdougall et al. AMERICAN JOURNAL OF NEPHROLOGY
- Pharmacokinetics of Polymersomes Composed of Poly(Butadiene-Ethylene Oxide); Healthy versus Tumor-Bearing Mice
- (2016) G. Wang et al. Journal of Biomedical Nanotechnology
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
- (2016) Peter P. Wibroe et al. JOURNAL OF CONTROLLED RELEASE
- Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy
- (2016) L. Simon-Gracia et al. MOLECULAR CANCER THERAPEUTICS
- Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
- (2015) Miguel J. Gil-Gil et al. BREAST CANCER RESEARCH AND TREATMENT
- The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes
- (2015) Paul H. Kierstead et al. JOURNAL OF CONTROLLED RELEASE
- Polymersomes and their applications in cancer delivery and therapy
- (2015) Lijuan Guan et al. Nanomedicine
- Nanoparticles of the poly([N-(2-hydroxypropyl)]methacrylamide)-b-poly[2-(diisopropylamino)ethyl methacrylate] diblock copolymer for pH-triggered release of paclitaxel
- (2015) Alessandro Jäger et al. Polymer Chemistry
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions
- (2015) Qi Yang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles
- (2013) Can Cui et al. BIOMATERIALS
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Hand-foot syndrome related to chemotherapy
- (2012) J. Qiao et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
- (2012) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester
- (2012) Eliézer Jäger et al. JOURNAL OF CONTROLLED RELEASE
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- In Vivo Evaluation of Doxorubicin-Loaded (PEG)3-PLA Nanopolymersomes (PolyDoxSome) Using DMBA-Induced Mammary Carcinoma Rat Model and Comparison with Marketed LipoDox™
- (2012) Wubeante Yenet Ayen et al. PHARMACEUTICAL RESEARCH
- Smart polymersomes for therapy and diagnosis: fast progress toward multifunctional biomimetic nanomedicines
- (2012) Hugo De Oliveira et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: Comparison with stealth liposomes
- (2011) Jung Seok Lee et al. JOURNAL OF CONTROLLED RELEASE
- The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice
- (2011) Kamal Kumar Upadhyay et al. Nanomedicine-Nanotechnology Biology and Medicine
- pH-triggered block copolymer micelles based on a pH-responsive PDPA (poly[2-(diisopropylamino)ethyl methacrylate]) inner core and a PEO (poly(ethylene oxide)) outer shell as a potential tool for the cancer therapy
- (2011) Fernando C. Giacomelli et al. Soft Matter
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes
- (2010) Kamal K. Upadhyay et al. BIOMATERIALS
- Polymersomes, smaller than you think: ferrocene as a TEM probe to determine core structure
- (2010) A. H. Johnston et al. JOURNAL OF NANOPARTICLE RESEARCH
- Polymersome production on a microfluidic platform using pH sensitive block copolymers
- (2010) Luke Brown et al. LAB ON A CHIP
- Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy
- (2010) Kai Yang et al. NANO LETTERS
- Camptothecin induces DNA strand breaks and is cytotoxic in stimulated normal lymphocytes
- (2010) Yamauchi ONCOLOGY REPORTS
- HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance☆
- (2009) Tamara Minko ADVANCED DRUG DELIVERY REVIEWS
- Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group
- (2008) N. Katsumata et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now